RDHL.TA - RedHill Biopharma Ltd.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Currency in ILS

Valuation Measures

Market Cap (intraday) 5845.22M
Enterprise Value 3672.94M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)131.00
Price/Book (mrq)2,329.41
Enterprise Value/Revenue 3104.30
Enterprise Value/EBITDA 6-13.21

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-790.76%

Management Effectiveness

Return on Assets (ttm)-54.98%
Return on Equity (ttm)-98.45%

Income Statement

Revenue (ttm)6.45M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.88M
EBITDA -50.93M
Net Income Avi to Common (ttm)-46.88M
Diluted EPS (ttm)-0.25
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.35M
Total Cash Per Share (mrq)0.17
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.20
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)-43.94M
Levered Free Cash Flow (ttm)-29.32M

Trading Information

Stock Price History

Beta 0.15
52-Week Change 325.86%
S&P500 52-Week Change 313.91%
52 Week High 3403.00
52 Week Low 3157.00
50-Day Moving Average 3263.53
200-Day Moving Average 3206.97

Share Statistics

Avg Vol (3 month) 3271.89k
Avg Vol (10 day) 3206.62k
Shares Outstanding 5213.44M
Float 180.37M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A